These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15864572)

  • 21. Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation.
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Invest Urol; 1981 Mar; 18(5):382-6. PubMed ID: 6162821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents.
    Sheng X; Jung T; Wesson JA; Ward MD
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):267-72. PubMed ID: 15625112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules.
    Wesson JA; Worcester EM; Wiessner JH; Mandel NS; Kleinman JG
    Kidney Int; 1998 Apr; 53(4):952-7. PubMed ID: 9551403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.
    Hess B; Nakagawa Y; Coe FL
    Am J Physiol; 1989 Jul; 257(1 Pt 2):F99-106. PubMed ID: 2750929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers.
    Tsujihata M; Tsujikawa K; Tei N; Yoshimura K; Okuyama A
    Int J Urol; 2006 Mar; 13(3):197-201. PubMed ID: 16643608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation.
    Drach GW; Thorson S; Randolph A
    J Urol; 1980 Apr; 123(4):519-23. PubMed ID: 7365890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
    Jaggi M; Nakagawa Y; Zipperle L; Hess B
    Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
    Bergsland KJ; Kinder JM; Asplin JR; Coe BJ; Coe FL
    J Urol; 2002 Jun; 167(6):2372-6. PubMed ID: 11992040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effects of human urine on the adhesion of calcium oxalate crystal to renal tubular cells].
    Umehara M
    Nihon Hinyokika Gakkai Zasshi; 1998 Dec; 89(12):949-55. PubMed ID: 9990226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamm-Horsfall glycoprotein--inhibitor or promoter of calcium oxalate monohydrate crystallization processes?
    Hess B
    Urol Res; 1992; 20(1):83-6. PubMed ID: 1736492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal agglomeration is a major element in calcium oxalate urinary stone formation.
    Kok DJ; Papapoulos SE; Bijvoet OL
    Kidney Int; 1990 Jan; 37(1):51-6. PubMed ID: 2299809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystallisation properties in stone forming and normal subjects' urine diluted using a standardised procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct.
    Tiselius HG; Hallin A; Lindbäck B
    Urol Res; 2001 Apr; 29(2):75-82. PubMed ID: 11396732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adhesion between molecules and calcium oxalate crystals: critical interactions in kidney stone formation.
    Sheng X; Ward MD; Wesson JA
    J Am Chem Soc; 2003 Mar; 125(10):2854-5. PubMed ID: 12617634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate.
    Fleming DE; Van Riessen A; Chauvet MC; Grover PK; Hunter B; van Bronswijk W; Ryall RL
    J Bone Miner Res; 2003 Jul; 18(7):1282-91. PubMed ID: 12854839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium-binding proteins and renal lithiasis.
    Resnick MI; Gammon CW; Sorrell MB; Boyce WH
    Surgery; 1980 Aug; 88(2):239-43. PubMed ID: 7394705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro.
    Atmani F; Khan SR
    BJU Int; 2000 Apr; 85(6):621-5. PubMed ID: 10759652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary calcium oxalate crystal growth inhibitors.
    Worcester EM
    J Am Soc Nephrol; 1994 Nov; 5(5 Suppl 1):S46-53. PubMed ID: 7873744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.